相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Poly(ethylene glycol)-block-poly(D,L-lactic acid) micelles containing oligo (lactic acid)8-paclitaxel prodrug: In Vivo conversion and antitumor efficacy
Yu Tong Tam et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Oligo(Lactic Acid)8-Rapamycin Prodrug-Loaded Poly(Ethylene Glycol)-block-Poly(Lactic Acid) Micelles for Injection
Yu Tong Tam et al.
PHARMACEUTICAL RESEARCH (2019)
Entrapping Instantly-Cleaved CPT Prodrugs in Polymeric Micelles for CPT Delivery
Fuyue Liu et al.
CHEMISTRYSELECT (2019)
Stereocomplex Prodrugs of Oligo(lactic acid)(n)-Gemcitabine in Polyethylene glycol)biock-poly(D,L-lactic acid) Micelles for Improved Physical Stability and Enhanced Antitumor Efficacy
Yu Tong Tam et al.
ACS NANO (2018)
The expanding role of prodrugs in contemporary drug design and development
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma
Hangxiang Wang et al.
THERANOSTICS (2018)
Micelles Structure Development as a Strategy to Improve Smart Cancer Therapy
Nemany A. N. Hanafy et al.
CANCERS (2018)
Structure-Guided Engineering of Cytotoxic Cabazitaxel for an Adaptive Nanoparticle Formulation: Enhancing the Drug Safety and Therapeutic Efficacy
Jianqin Wan et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug Delivery
Yang Shi et al.
MACROMOLECULAR BIOSCIENCE (2017)
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA
Stephane Oudard et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy
Feihu Wang et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Clinical application of polymeric micelles for the treatment of cancer
Aida Varela-Moreira et al.
MATERIALS CHEMISTRY FRONTIERS (2017)
Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity
Yu Tong Tam et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy
Yiming Zhao et al.
NATURE COMMUNICATIONS (2016)
Polymeric micelle nanocarriers in cancer research
Dae Hwan Shin et al.
FRONTIERS OF CHEMICAL SCIENCE AND ENGINEERING (2016)
Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy
Xinpeng Ma et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Polymeric Micelles for Multi-Drug Delivery in Cancer
Hyunah Cho et al.
AAPS PHARMSCITECH (2015)
Recent trends in the design of anticancer polymer prodrug nanocarriers
Vianney Delplace et al.
POLYMER CHEMISTRY (2014)
Prodrug Strategy to Achieve Lyophilizable, High Drug Loading Micelle Formulations Through Diester Derivatives of β-Lapachone
Xinpeng Ma et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Prediction of nanoparticle prodrug metabolism by pharmacokinetic modeling of biliary excretion
Stephan T. Stern et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs
Wei Xu et al.
JOURNAL OF DRUG DELIVERY (2013)
Block copolymer micelles as long-circulating drug vehicles
Glen S. Kwon et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Block copolymer micelles for drug delivery: Design, characterization and biological significance
Kazunori Kataoka et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Cancer Therapies Utilizing the Camptothecins: A Review of the in Vivo Literature
Vincent J. Venditto et al.
MOLECULAR PHARMACEUTICS (2010)
Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats
May P. Xiong et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Modulating the therapeutic activity of nanoparticle delivered paclitaxel by manipulating the hydrophobicity of prodrug conjugates
Steven M. Ansell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: Pharmacokinetic disposition, tolerability, and cytotoxicity
M. Laird Forrest et al.
PHARMACEUTICAL RESEARCH (2008)
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer:: A randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
Richard Herrmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(ε-caprolactone) micelles
M. Laird Forrest et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Enzymes involved in the bioconversion of ester-based prodrugs
Bianca M. Liederer et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Hydrolytic degradation of oligo(lactic acid): a kinetic and mechanistic study
CF van Nostrum et al.
POLYMER (2004)
Polymer-drug compatibility: A guide to the development of delivery systems for the anticancer agent, Ellipticine
JB Liu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery
A Lavasanifar et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
分享论文
